In a matter involving an antitrust counterclaim, a generic pharmaceutical manufacturer alleged that a blockbuster brand manufacturer attempted to monopolize the market and delay entry of the generic product. A CRA expert was retained to analyze market definition, competitive effects, and lost profits damages estimates. The matter settled favorably for our client shortly before trial.
Lars Wiethaus' Q&A with Who's Who Legal
CRA’s Lars Wiethaus was ranked as a Global Elite Thought Leader in Competition by Who’s Who Legal in their 2022 rankings. In an interview with Who’s Who Legal,...